Form 8-K - Current report:
SEC Accession No. 0001193125-19-015976
Filing Date
2019-01-24
Accepted
2019-01-24 16:34:03
Documents
7
Period of Report
2019-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d694399d8k.htm 8-K 19523
2 EX-1.1 d694399dex11.htm EX-1.1 240677
3 EX-5.1 d694399dex51.htm EX-5.1 52410
4 EX-99.1 d694399dex991.htm EX-99.1 8752
5 GRAPHIC g694399g13p18.jpg GRAPHIC 16007
6 GRAPHIC g694399page1a.jpg GRAPHIC 3212
7 GRAPHIC g694399page1anew.jpg GRAPHIC 2482
  Complete submission text file 0001193125-19-015976.txt   353158
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 19540318
SIC: 2834 Pharmaceutical Preparations